Recombinant Rat CTGF Protein，His & GST

Connective Tissue Growth Factor (CTGF), also known as CCN2, is a multifaceted protein that plays a pivotal role in various physiological and pathological processes, including fibrosis, wound healing, and tissue repair. Initially identified as a secreted factor associated with cell proliferation and extracellular matrix formation, CTGF is of particular interest in the context of fibrotic diseases and inflammatory responses due to its ability to regulate cellular functions and promote collagen synthesis. Research has shown that abnormal CTGF expression is implicated in disorders such as systemic sclerosis, kidney fibrosis, and chronic liver diseases. The exploration of CTGF as a therapeutic target has gained momentum, with recombinant CTGF protein being studied for its potential to modulate fibrotic pathways. Various experimental models have demonstrated the protein's effects on cellular migration, proliferation, and ECM remodeling, making it a crucial player in tissue homeostasis. Furthermore, the development of CTGF inhibitors and their therapeutic applications in fibrotic conditions highlight the urgency in understanding its molecular mechanisms. This growing body of research positions CTGF not only as a vital biomarker for fibrotic diseases but also as a promising candidate for novel therapeutic strategies aimed at mitigating fibrosis and enhancing tissue regeneration. However, further studies are required to elucidate the detailed signaling pathways and interactions involving CTGF, ultimately paving the way for clinical applications that harness its properties in regenerative medicine and fibrotic disease management.